🇦🇪 Yorvipath in United Arab Emirates

Yorvipath (PALOPEGTERIPARATIDE) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Marketing authorisation holder: ASCENDIS PHARMA BONE
  • Status: likely_approved

Yorvipath in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Nephrology approved in United Arab Emirates

Frequently asked questions

Is Yorvipath approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Yorvipath in United Arab Emirates?

ASCENDIS PHARMA BONE holds the UAE marketing authorisation.